Meclizine Hydrochloride Tablet
Product Images NDC 16571-660

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Meclizine Hydrochloride (NDC 16571-660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

12.5mg (12 5mg 100ct)

Rising 66001 is a medication used for the treatment of vertigo. It contains Meclizine and is available in tablet form. Each tablet is distributed by SGE T61 in a bottle. The accompanying prescription information has a code of TS DRUGS/22/2008. The tablets are dependent on the clinical response of the patient. The medication should be stored at a temperature of 20 to 25°C and kept out of reach of children. The text appears to be a label or package insert for the medication.*

FDA Label Image

25mg-100ct-chew (25mg 100ct Chew)

FDA Label Image

25mg-100ct (25mg 100ct)

Rising® NDC 16571-661-01 presents Meclizine Hydrochloride Tablets, USP containing 25 mg meclizine dihydrochloride equivalent to 102107 mg of meclizine free base. The recommended dosage for vertigo varies depending on the clinical response, and it is suggested to consult with the accompanying prescribing information. The medication should be stored in a tight, light-resistant container and kept out of reach of children. The drug is distributed by Rising Pharmaceuticals, Inc. and made in India. The code, LAgs101-00, and some additional information are also provided.*

FDA Label Image

50mg-100ct (50mg 100ct)

Rising® NDC 16571-662-01 produces Meclizine Hydrochloride tablets, USP. Each tablet contains 50mg meclizine dihydrochloride equivalent to T042.14 mg of meclizine free base. It is used to treat vertigo and should be taken in divided doses of 25mg to 100mg daily, depending on clinical response. The prescribing information has usual dosage. The medication should be kept out of reach of children and stored in a tight, light-resistant container at 20° to 25°C (68° to T7°F) as per USP controlled room temperature. It is made in India and distributed by Rising Pharmaceuticals. Code: TS/DAUGS/22/2008. (Issued: 08/2019).*

FDA Label Image

Struct-1 (Struct 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.